Drug-eluting stents: European medicinal products guideline now ready
This article was originally published in Clinica
Executive Summary
In the light of work that is ongoing at the European Commission’s medical device Clinical Evaluations Task Force (CETF) on drug-eluting stents, the European Medicines Agency (EMEA) has made substantial amendments to its final guideline on clinical and non-clinical evaluation of medicinal substances in drug eluting stents (DESs).